A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
Clinical trial NCT03065959 · TERMINATED
Trial details
- NCT number
- NCT03065959
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2018-10-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.